Lorena Amezquita

Lorena Amezquita

Auto-generated profile, based on publicly available information

Lorena Amezquita

Fundación Universitaria de Ciencias de la Salud (FUCS) Bogotá Colombia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2019 in Journal of Cellular Physiology
Verified
Journal Article
Open access
PDF file
LGLuz Dary Gutierrez GUTIERREZ-CASTAÑEDA
Luz Dary Gutierrez GUTIERREZ-CASTAÑEDA
JPJose David Tovar Parra
Jose David Tovar Parra
GQGloria Quintero
Gloria Quintero
LALorena Amezquita
Lorena Amezquita
CGCarlos Guerrero
Carlos Guerrero
DSDaniel Sanabria
Daniel Sanabria
Ovarian cancer is the fifth leading cause of cancer‐related deaths. It causes approximately 125,000 deaths per year worldwide; its diagnosis is made in advanced stages resulting in a high mortality rate. The objective of the study was optimizing the isolation of cells obtained from the solid tumor and ascitic fluid of patients with ovarian cancer and the phenotype with markers related to the epithelial–mesenchymal transition. For this, the solid tumor tissue was disaggregated and cultivated with different methodologies. As a result, cell growth was obtained and epi‐immunofluorescence was performed using antibodies against E‐cadherin, EpCAM, N‐cadherin, vimentin, CD133, and CD44. The primary culture from the solid tumor was obtained using Dispase II and DMEM/F12. Finally, heterogeneity was detected in terms of the expression of mesenchymal and epithelial type markers in the two types of isolated cells. Additionally, CD133 and CD44 expression was detected, proteins associated with the tumor stem cells phenotype.